Acute Fulminant Mucormycosis Triggered by Covid 19 Infection in a Young Patient

Area of Science:

• Infectious Diseases
• Critical Care Medicine
• Ophthalmology

Background:

• COVID-19 can lead to opportunistic infections due to altered immunity and comorbidities.
• Risk factors include diabetes, steroid use, and intensive care unit (ICU) interventions.
• Mucormycosis is a severe fungal infection that can occur in immunocompromised patients.

Purpose of the Study:

• To report a rare case of severe, acute fulminant mucormycosis in a COVID-19 patient.
• To emphasize the importance of high suspicion and early aggressive management.
• To discuss the challenges in treating co-existing COVID-19 and mucormycosis.

Main Methods:

• Case report of a 31-year-old male with COVID-19 and new-onset diabetes.
• Presentation included severe headache, ophthalmoplegia, blindness, and Cavernous Sinus Thrombosis.
• Treatment involved aggressive surgical debridement, orbital decompression, and Liposomal amphotericin B.

Main Results:

• The patient developed a temporal lobe abscess post-operatively, requiring further endoscopic drainage.
• At 2 months follow-up, the patient had bilateral blindness but tolerated oral feeds with improved left eye function.
• This case underscores the rising incidence of mucormycosis in COVID-19 patients.

Conclusions:

• COVID-19 patients, especially those with diabetes, are at increased risk for mucormycosis.
• High index of suspicion and prompt, aggressive multidisciplinary treatment are vital for improving survival rates.
• Management requires addressing both the fungal infection and the underlying immunocompromised state.